Understanding common peptide mass shift caused by side reactions is essential for accurate LC-MS data interpretation in peptide synthesis and analysis.
| Nominal Mass Shift [Da] | Monoisotopic Mass Shift [Da] | Average Mass Shift [Da] | Net Formula Delta | Affected Residue(s) | Modification |
|---|---|---|---|---|---|
| – | All | Dipeptide Masses | |||
| – | N-term | Diketopiperazine (DKP) Formation | |||
| -36 | -36.021129 | -36.030000 | H-4O-2 | D, E, S, T, N, Q | Dehydration (2 x H2O) |
| -34 | -33.987721 | -34.076000 | H-2S-1 | C | Cysteine beta-elimination (Dehydroalanine) |
| -48 | -48.003371 | -48.103000 | C-1H-4S-1 | M | Homoserine lactone artifact (Hsl) from CNBr cleavage at Met |
| -30 | -29.992807 | -30.088000 | C-1H-2OS-1 | M | Homoserine artifact (ring-opened homoserine lactone) from CNBr cleavage at Met |
| -18 | -18.010565 | -18.015000 | H-2O-1 | D, E, S, T, N, Q | Dehydration (1 x H2O) |
| -18 | -18.010565 | -18.015000 | H-2O-1 | D | Aspartimide (succinimide) formation from Asp |
| -18 | -18.010565 | -18.015000 | H-2O-1 | E | Pyroglutamate or Glutarimide Formation on Glu |
| -17 | -17.026549 | -17.031000 | H-3N-1 | N | Aspartimide (succinimide) formation from Asn |
| -17 | -17.026549 | -17.031000 | H-3N-1 | Q | Pyroglutamate or Glutarimide Formation on Gln |
| -2 | -2.015650 | -2.016000 | H-2 | C | Disulfide Bond Formation; Cysteine Oxidation |
| -2 | -2.015650 | -2.016000 | H-2 | C | Cysteine Sulfenamide Formation |
| -1 | -0.984016 | -0.984000 | HNO-1 | C-term, D, E | Amidation of Carboxylic Group |
| 0 | 0.000000 | 0.000000 | 0 | All | Peptide Modifications With Identical Masses |
| 1 | 0.984016 | 0.984000 | H-1N-1O | C-term | C-Terminal Amide Group Hydrolysis |
| 1 | 0.984016 | 0.984000 | H-1N-1O | N, Q | Hydrolysis/deamidation of Asn or Gln side chains to Asp or Glu (not aspartimide formation) |
| 1 | 0.984016 | 0.984000 | H-1N-1O | R | Deimination of Arginine side chain to Citrulline |
| 2 | 2.015650 | 2.016000 | H2 | C | Disulfide Bond (Cystine) Reduction |
| 2 | 2.015650 | 2.016000 | H2 | W | Reduction of Trp Side Chain Groupe (Indole) |
| 4 | 3.994915 | 3.988000 | C-1O | W | Oxidation of Trp to Kynurenine |
| 12 | 12.000000 | 12.011000 | C | N-term, K, C, W | Formaldehyde adduct (plastic leachable or solvent impurity, usually on Cys, Trp, or N-terminus) |
| 14 | 14.015650 | 14.027000 | CH2 | C-term, D, E | Methyl Esterification of the Carboxyl Groups |
| 14 | 14.015650 | 14.027000 | CH2 | N-term, K | N-Methylation |
| 14 | 13.979265 | 13.983000 | H-2O | C | Thiosulfinate Formation |
| 16 | 15.994915 | 15.999000 | O | M | Methionine Oxidation |
| 16 | 15.994915 | 15.999000 | O | C | Oxidation of Cysteine to Cysteine Sulfenic Acid |
| 16 | 15.994915 | 15.999000 | O | H | Oxidation of Histidine to 2-O-Histidine |
| 16 | 15.994915 | 15.999000 | O | W | Oxidation of Tryptophan to Oxindolylalanine (Trp to Oia) |
| 16 | 15.994915 | 15.999000 | O | C | Thiosulfinate Formation |
| 22 | 21.981944 | 21.981770 | H-1Na | All | Sodium cation adduct (replacement of one proton) |
| 28 | 28.031300 | 28.054000 | C2H4 | N-term, K | N,N-Dimethylation |
| 28 | 27.994915 | 28.010000 | CO | N-term | N-terminal formylation (frequently caused by degraded DMF solvent) |
| 30 | 29.974179 | 29.982000 | H-2O2 | C | Thiosulfonate Formation |
| 32 | 31.972071 | 32.060000 | S | C | Trisulfide Bond Formation |
| 32 | 31.989829 | 31.998000 | O2 | M | Methionine Oxidation |
| 32 | 31.989829 | 31.998000 | O2 | C | Cysteine Sulfinic Acid Formation |
| 32 | 31.989829 | 31.998000 | O2 | C | Thiosulfonate Formation |
| 32 | 31.989829 | 31.998000 | O2 | W | Oxidation of Tryptophan to N-Formylkynurenine |
| 34 | 33.961028 | 34.442000 | H-1Cl | Y, W | Monochlorination artifact (e.g., Tyrosine modification from bleach or scavenger traces) |
| 38 | 37.955881 | 38.090300 | H-1K | All | Potassium cation adduct (replacement of one proton) |
| 40 | 40.031300 | 40.065000 | C3H4 | S, T | Serine or Threonine Pseudoproline (Psi-Me,MePro) |
| 42 | 42.010565 | 42.037000 | C2H2O | N-term, K | Acetylation |
| 43 | 43.005814 | 43.025000 | CHNO | N-term, K | Carbamylation of primary amines (common artifact when using urea buffers) |
| 44 | 43.989829 | 44.009000 | CO2 | W | Incomplete Tryptophan Boc Group Removal (residual CO2/carbamate; full retained Boc is +100 Da) |
| 48 | 47.984744 | 47.997000 | O3 | C | Cysteine Sulfonic Acid Formation |
| 51 | 51.101428 | 51.074000 | C5H9NS-1 | C | Fmoc-Cys(Acm)-OH or Fmoc-Cys(Trt)-OH Side Reaction with Piperidine |
| 56 | 56.062600 | 56.108000 | C4H8 | C, M, W, Y | Peptide tert-Butylation (monoalkylated) |
| 57 | 57.021464 | 57.052000 | C2H3NO | G | Glycine Mass Shift |
| 57 | 57.070425 | 57.116000 | C4H9 | M | Methionine Tert-Butylation (monoalkylated) |
| 65 | 65.117078 | 65.101000 | C6H11NS-1 | C | Cys Side Reaction with 4-Methylpiperidine |
| 67 | 67.078585 | 67.135000 | C5H9NO-1 | D | Piperidide Peptide from Asp |
| 68 | 68.062600 | 68.119000 | C5H8 | N | Piperidide Peptide from Asn |
| 71 | 71.037114 | 71.079000 | C3H5NO | A | Alanine Mass Shift |
| 71 | 71.037114 | 71.079000 | C3H5NO | C | Acetamidomethyl (Acm) protecting group |
| 78 | 77.910513 | 78.896000 | H-1Br | Y, W | Monobromination artifact (e.g., on Tyrosine; monoisotopic +77.91, average +78.90) |
| 80 | 79.956815 | 80.057000 | O3S | R, W, Y | Sulfonation (net SO3 addition; often described as SO3H addition) |
| 80 | 79.966331 | 79.978762 | HO3P | S, T, Y | Phosphorylation (addition of phosphate to Ser, Thr, or Tyr) |
| 92 | 91.975442 | 92.174000 | C2H4S2 | C | Cysteine-EDT Adduct Formation |
| 96 | 95.982299 | 96.008209 | C2H-1F3O | N-term, K, S, T, Y | Trifluoroacetylation of -NH2 or -OH groups |
| 97 | 97.052764 | 97.117000 | C5H7NO | P | Proline Mass Shift |
| 98 | 98.071822 | 98.129000 | C4H8N3 | N-term, K | Guanidinium Formation on Amino Group |
| 99 | 99.068414 | 99.133000 | C5H9NO | V | Valine Mass Shift |
| 100 | 100.052429 | 100.117000 | C5H8O2 | N-term, K, W | tert-Butyloxycarbonyl (Boc) |
| 101 | 101.047678 | 101.105000 | C4H7NO2 | T | Threonine Miss Coupling |
| 103 | 103.009185 | 103.139000 | C3H5NOS | C | Cysteine Mass Shift |
| 106 | 106.041865 | 106.124000 | C7H6O | C, W, C-term | Cys, Trp, or C-Terminys Alkylation by Wang Resin Linker: 4-Hydroxylbenzylation |
| 112 | 112.125201 | 112.216000 | C8H16 | C, M, W, Y | Peptide tert-Butylation (dialkylated) |
| 113 | 113.084064 | 113.160000 | C6H11NO | I | Isoleucine Mass Shift |
| 113 | 113.084064 | 113.160000 | C6H11NO | L | Leucine Mass Shift |
| 114 | 114.042927 | 114.104000 | C4H6N2O2 | N | Asparagine Mass Shift |
| 114 | 114.140851 | 114.232000 | C8H18 | M | Methionine Tert-Butylation (dialkylated) |
| 115 | 115.026943 | 115.088000 | C4H5NO3 | D | Aspartate Mass Shift |
| 117 | 117.073797 | 117.230000 | C6H13S | M | Methionine Alkylation dy DODT |
| 128 | 128.058578 | 128.131000 | C5H8N2O2 | Q | Glutamine Mass Shift |
| 128 | 128.094963 | 128.175000 | C6H12N2O | K | Lysine Mass Shift |
| 129 | 129.042593 | 129.115000 | C5H7NO3 | E | Glutamate Mass Shift |
| 131 | 131.040485 | 131.193000 | C5H9NOS | M | Methionine Mass Shift |
| 134 | 134.036779 | 134.134000 | C8H6O2 | N-term, K | Benzyloxycarbonyl (Cbz or Z) protecting group |
| 137 | 137.058912 | 137.142000 | C6H7N3O | H | Histidine Mass Shift |
| 147 | 147.068414 | 147.177000 | C9H9NO | F | Phenylalanine Mass Shift |
| 148 | 148.038043 | 148.282000 | C6H12S2 | C | Cysteine-EDT-tBu Adduct Formation |
| 154 | 154.008851 | 154.183000 | C7H6O2S | R, H | Tosyl (Tos) protecting group |
| 156 | 156.101111 | 156.189000 | C6H12N4O | R | Arginine Mass Shift |
| 160 | 159.913630 | 160.114000 | O6S2 | R, W, Y | Disulfonation (2xSO3H) |
| 163 | 163.063329 | 163.176000 | C9H9NO2 | W | Rink amide MBHA linker Trp Alkylation |
| 163 | 163.063329 | 163.176000 | C9H9NO2 | Y | Tyrosine Mass Shift |
| 166 | 166.001457 | 166.092000 | C6H2N2O4 | N-term, K, H | 2,4-Dinitrophenyl (Dnp) modification |
| 172 | 171.962827 | 172.183209 | C4H3F3S2 | W | Trp-EDT-TFA Cyclic Adduct |
| 178 | 178.078250 | 178.234000 | C14H10 | N-term, K, C, W | Dibenzofulvene Peptide Alkylation |
| 186 | 186.079313 | 186.214000 | C11H10N2O | W | Tryptophan Mass Shift |
| 202 | 202.024164 | 202.132209 | C9H5F3O2 | C, W, C-term | Trp, Cys, or C-Terminus Alkylation by Wang Resin Linker: 4-Trifluoroacetyoxybenzylation |
| 212 | 212.050715 | 212.263000 | C10H12O3S | R | 4-Methoxy-2,3,6-trimethylbenzenesulfonyl (Mtr) |
| 212 | 212.083730 | 212.248000 | C14H12O2 | W | Trp 4-Hydroxylbenzyl Dialkylation by Wang Resin Linker |
| 222 | 222.068080 | 222.243000 | C15H10O2 | N-term, K | Fmoc group |
| 226 | 226.077599 | 226.294000 | C10H14N2O2S | N-term, K | Biotinylation tag (via amide bond) |
| 233 | 233.051050 | 233.285000 | C12H11NO2S | N-term, K | Dansyl (Dns) fluorescent tag |
| 242 | 242.109550 | 242.321000 | C19H14 | C, H, N, Q | Trtylation |
| 252 | 252.082016 | 252.328000 | C13H16O3S | R | Pbf Derivative |
| 265 | 265.131408 | 265.309000 | C14H19NO4 | W | Tryptophan-Pal linker Alkylation |
| 266 | 266.097666 | 266.355000 | C14H18O3S | R | Pmc Derivative |
| 274 | 274.099380 | 274.319000 | C19H14O2 | C | Cysteine Sulfinic Acid + Trt Group Derivative |
| 308 | 308.066029 | 308.256209 | C16H11F3O3 | W | Trp 4-Hydroxylbenzyl and 4-Trifluoroacetyloxybenzyl Dialkylation (Wang Resin Linker) |
| 359 | 358.047738 | 358.305000 | C21H10O6 | N-term, K, C | Fluorescein label addition (FAM/carboxyfluorescein amide; reagent-dependent) |
| 404 | 404.048328 | 404.264419 | C18H10F6O4 | W | Trp 4-Trifluoroacetyloxybenzyl Dialkylation (Wang Resin Linker) |
Optimize Your Synthesis Strategy with Peptalyzer™
While this peptide mass shift table helps you diagnose what happened in the flask, Peptalyzer™ helps you prevent it. Run a Chemical Stability Audit on your target sequence to identify oxidation-prone residues, aspartimide hotspots, and sequence-dependent risks before you even weigh out your resin.
Interpreting Peptide Mass Shift Patterns from Common Side Reactions
Unexpected peptide mass shifts (ΔM) frequently result from well-characterized side reactions occurring during Fmoc-SPPS, TFA cleavage, or purification. Identifying these precise mass deviations is critical for diagnosing synthetic bottlenecks—whether it’s an incomplete protecting group removal (e.g., +252 Da Pbf adducts), a scavenger artifact, or an unintended oxidation.
This mass shift table provides a rapid diagnostic reference for common synthetic modifications. Use the Affected Residue(s) column to cross-reference unexpected peaks against your target sequence. Where applicable, click on highlighted modifications for detailed mechanistic explanations and prevention strategies.
Peptide Mass Shift — FAQ
True covalent modifications (like unremoved protecting groups or oxidations) are distinct chemical entities. They will typically have a different HPLC retention time than your target peptide. Conversely, LC-MS artifacts—such as metal adducts (Sodium +22 Da, Potassium +38 Da) or in-source fragmentation—occur during the ionization process inside the mass spectrometer. If the shifted mass perfectly co-elutes with your main product peak, it is highly likely to be an ionization artifact rather than a synthesis failure.
If a mass shift does not match a single entry, it is frequently a combination of multiple side reactions or adducts. For instance, a +38 Da shift might not be a single event; it could be an oxidation (+16 Da) combined with a Sodium adduct (+22 Da). When troubleshooting an unknown mass, always subtract common ionization adducts first, then look for combinations of expected protecting groups based on your sequence.
Chemical artifacts are highly residue-specific. You can drastically reduce your troubleshooting time by cross-referencing your observed mass shift with the Affected Residue(s) column. For example, if you see a +16 Da shift but your sequence lacks Methionine, Cysteine, Tryptophan, or Histidine, you can safely rule out standard oxidation and start investigating alternative causes, such as a synthesis deletion or a solvent contaminant.
Chemical artifacts are highly residue-specific. You can drastically reduce your troubleshooting time by cross-referencing your observed mass shift with the Affected Residue(s) column. For example, if you see a +16 Da shift but your sequence lacks Methionine, Cysteine, Tryptophan, or Histidine, you can safely rule out standard oxidation and start investigating alternative causes, such as a synthesis deletion or a solvent contaminant.
Yes. While this mass shift table is designed for post-synthesis LC-MS troubleshooting, you can take a proactive approach using the Chemical Stability Audit in Peptalyzer™. By inputting your target sequence before beginning your synthesis, Peptalyzer automatically scans for high-risk sequence motifs (such as Asp-Gly for aspartimide formation, or N-terminal Gln for pyroglutamate). This allows you to anticipate potential mass shifts and adjust your synthetic strategy—such as utilizing Dmb-protected dipeptides—before wasting reagents.
The mass shift table is an exhaustive diagnostic reference that includes unpredictable, environmentally dependent artifacts—such as metal adducts (+22 Da Na+), solvent contaminants (formylation), or incomplete scavenger trapping. In contrast, the Peptalyzer™ Chemical Stability Audit focuses purely on sequence-dependent chemical risks (like oxidation-prone Met/Trp/Cys residues or specific degradation motifs). Peptalyzer predicts what is structurally likely to happen based on your sequence, while this table helps you diagnose what actually happened in the flask.